| Leonard B Kamen, DO | |
|
60 Township Line Rd, Elkins Park, PA 19027-2220 | |
| (215) 663-6600 | |
| (215) 663-6265 |
| Full Name | Leonard B Kamen |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 41 Years |
| Location | 60 Township Line Rd, Elkins Park, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760577324 | NPI | - | NPPES |
| 1103049 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | OS005508L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Albert Einstein Medical Center | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Einstein Practice Plan Inc | 2769395896 | 591 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
UT Southwestern Medical Center neurology researchers have identified an important cell signaling mechanism that plays an important role in brain cancer and may provide a new therapeutic target.
Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death, heart attack or stroke among patients with type 2 diabetes and recent heart attack or unstable angina, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions.
Certain rare mutations in the ataxia telangiectasia mutated gene, combined with radiation exposure, may increase a woman's risk of developing a second cancer in the opposite breast, according to a study published online March 19 in the Journal of the National Cancer Institute.
Santarus, Inc., a specialty biopharmaceutical company, today announced that pursuant to its distribution and supply agreement with Prasco, LLC, Prasco is commencing shipments of an authorized generic of prescription ZEGERID® (omeprazole/ sodium bicarbonate) Capsules in 20 mg and 40 mg dosage strengths in the U.S. under the Prasco label. ZEGERID is an immediate-release proton pump inhibitor (PPI) approved as a prescription product in the U.S. for the treatment of certain upper gastrointestinal diseases and disorders.
› Verified 9 days ago
| Entity Name | Einstein Practice Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760434468 PECOS PAC ID: 2769395896 Enrollment ID: O20040219000728 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
UT Southwestern Medical Center neurology researchers have identified an important cell signaling mechanism that plays an important role in brain cancer and may provide a new therapeutic target.
Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death, heart attack or stroke among patients with type 2 diabetes and recent heart attack or unstable angina, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions.
Certain rare mutations in the ataxia telangiectasia mutated gene, combined with radiation exposure, may increase a woman's risk of developing a second cancer in the opposite breast, according to a study published online March 19 in the Journal of the National Cancer Institute.
Santarus, Inc., a specialty biopharmaceutical company, today announced that pursuant to its distribution and supply agreement with Prasco, LLC, Prasco is commencing shipments of an authorized generic of prescription ZEGERID® (omeprazole/ sodium bicarbonate) Capsules in 20 mg and 40 mg dosage strengths in the U.S. under the Prasco label. ZEGERID is an immediate-release proton pump inhibitor (PPI) approved as a prescription product in the U.S. for the treatment of certain upper gastrointestinal diseases and disorders.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leonard B Kamen, DO 101 E Olney Ave, Suite 400, Philadelphia, PA 19120-2421 Ph: (215) 456-7000 | Leonard B Kamen, DO 60 Township Line Rd, Elkins Park, PA 19027-2220 Ph: (215) 663-6600 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
UT Southwestern Medical Center neurology researchers have identified an important cell signaling mechanism that plays an important role in brain cancer and may provide a new therapeutic target.
Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death, heart attack or stroke among patients with type 2 diabetes and recent heart attack or unstable angina, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions.
Certain rare mutations in the ataxia telangiectasia mutated gene, combined with radiation exposure, may increase a woman's risk of developing a second cancer in the opposite breast, according to a study published online March 19 in the Journal of the National Cancer Institute.
Santarus, Inc., a specialty biopharmaceutical company, today announced that pursuant to its distribution and supply agreement with Prasco, LLC, Prasco is commencing shipments of an authorized generic of prescription ZEGERID® (omeprazole/ sodium bicarbonate) Capsules in 20 mg and 40 mg dosage strengths in the U.S. under the Prasco label. ZEGERID is an immediate-release proton pump inhibitor (PPI) approved as a prescription product in the U.S. for the treatment of certain upper gastrointestinal diseases and disorders.
› Verified 9 days ago
Dr. Nicholas P Diamond, DO Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 8080 Old York Rd, Suite 208, Elkins Park, PA 19027 Phone: 215-782-8760 Fax: 215-635-7130 | |
Dr. Michael Marino, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 60 Township Line Rd, Elkins Park, PA 19027 Phone: 215-663-6677 Fax: 215-663-6265 | |
Dr. Jeffrey North, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 60 Township Line Rd, Elkins Park, PA 19027 Phone: 215-663-6677 Fax: 215-663-6265 | |
Gilbert Lafontant, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 60 Township Line Rd, Elkins Park, PA 19027 Phone: 215-662-6600 Fax: 215-254-2599 | |
Dr. Kristie Y Kim, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 60 Township Line Rd, Elkins Park, PA 19027 Phone: 215-663-6677 Fax: 215-663-6265 | |
Rebecca Samantha Ovsiowitz, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 333 Township Line Rd, Elkins Park, PA 19027 Phone: 215-663-9688 Fax: 215-663-9703 | |
Dr. Daniel K Moon, M.D., M.S. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 60 Township Line Rd, Elkins Park, PA 19027 Phone: 215-663-6000 |